3 Coronavirus Stocks With Long-Term Growth Potential
Abbott Laboratories (NYSE: ABT), Moderna (NASDAQ: MRNA), and Novavax (NASDAQ: NVAX) have each grown amid the new coronavirus market in different ways. Abbott's coronavirus testing business could make it the world's top COVID-19 diagnostic provider, and Moderna may be on track to become the biotech industry's first "software" therapeutics company while working on its potential coronavirus vaccine. And while its coronavirus vaccine candidate may not be the first to reach the market, Novavax could soon become the manufacturer of the most effective flu vaccine in the world.
Each of these companies has the potential to continue expanding. In the case of Moderna and Novavax, this future growth may be tremendous, whereas Abbott's will probably be more moderate. Let's investigate each stock to determine why they're growing and if they might be the right choice for your portfolio.
Image source: Getty Images.
Source Fool.com
